PharmExec Picks:
Having trouble viewing this e-mail? Click here.
feed back  
Update My Profile | Advertise With Us | Visit PharmExec.com | SUBSCRIBE

Pharm Exec Picks is a biweekly eletter that delivers the most popular news and articles from the pharma space and highlights what’s trending on social media.
Top 5 Stories :
Tech Giants Collaborate and Disrupt in Life Sciences Industry
As tech giants enter the life sciences industry, healthcare companies should adapt their business model and embark with these new players on a more ambitious, personalized, and preventive healthcare strategy.

Read more

 

 
A Fireside Chat with Brent Saunders, CEO of Allergan
At this year's Pharmaceutical Executive Summit on “Emerging Strategic, Financial and Shareholder Issues” on November 3, Peter Young sat down with Brent Saunders, CEO of Allergan, for a fireside chat about Saunders’ early entrepreneurial years, his career in the industry, and some of his business philosophies.
Read more

 
The 'Prosolidate' Push: New Agency Service Mix
To minimize the risks of consolidation, many brand leaders are embracing a new agency service model called “prosolidation” that adds independent agencies into the mix, breaking the decades-old trend of agency consolidation.
Read more

 

 
Regulators, Researchers Seek to Advance Research on Cellular & Gene Therapies
There’s renewed optimism in the biomedical research community that years of effort finally may begin to pay off for developing cutting-edge gene and cellular treatments for debilitating and life-threatening conditions. Jill Wechsler reports.
Read more

 
4A's Partner Award Pushes Healthcare Agencies Into the Spotlight
Healthcare agencies are being given a place at the table at ad industry’s top award shows. And while not close enough to rub elbows with the Don Drapers and Peggy Olsons of the ad world, at least they’re being invited, writes Marylyn Donahue.
Read more

 
Follow Us
 
Trending on Social Media :
Drug Pricing in Europe: A Discordant Bandwagon
The Parliamentary Assembly of the Council of Europe is the latest to clamber aboard the well-filled bandwagon now rumbling and rattling across Europe in an increasingly noisy debate over drug prices.
Read more

A ‘New’ Cancer Drugs Fund for England
The much awaited consultation on a ‘new’ Cancer Drugs Fund (CDF) in England has finally emerged. Leela Barham reports.
Read more

Sanofi and AstraZeneca Exchange More Than 200,000 Compounds
Sanofi and AstraZeneca have announced an exchange of 210,000 compounds from their respective proprietary compound libraries in an "open innovation" collaboration model.
Read more